Antiprostasome antibodies are not an appropriate prognostic marker for prostate cancer

References

• Ronquist G, Brody I. The prostasome: its secretion and function in man. Biochim Biophys Acta 1985; 822: 203–18
   PubMed Web of Science ®Google Scholar
• Utleg AG, Yi EC, Xie T, Shannon P, White JT, Goodlett DR, et al. Proteomic analysis of human prostasomes. Prostate 2003; 56: 150–61
   PubMed Web of Science ®Google Scholar
• Ronquist G, Nilsson BO, Hjerten S. Interaction between prostasomes and spermatozoa from human semen. Arch Androl 1990; 24: 147–57
   PubMed Web of Science ®Google Scholar
• Fabiani R, Johansson L, Lundkvist O, Ronquist G. Enhanced recruitment of motile spermatozoa by prostasome inclusion in swim-up medium. Hum Reprod 1994; 9: 1485–9
   PubMed Web of Science ®Google Scholar
• Carlsson L, Ronquist G, Stridsberg M, Johansson L. Motility stimulant effects of prostasome inclusion in swim-up medium on cryopreserved human spermatozoa. Arch Androl 1997; 38: 215–21
   PubMed Web of Science ®Google Scholar
• Arienti G, Carlini E, Saccardi C, Palmerini CA. Nitric oxide and fusion with prostasomes increase cytosolic calcium in progesterone-stimulated sperm. Arch Biochem Biophys 2002; 402: 255–8
   PubMed Web of Science ®Google Scholar
• Lilja H, Laurel CB. Liquefaction of coagulated human semen. Scand J Clin Lab Invest 1984; 44: 447–52
   PubMed Web of Science ®Google Scholar
• Rooney IA, Atkinson JP, Krul ES, Schonfeld G, Polakoski K, Saffitz JE, et al. Physiologic relevance of the membrane attack complex inhibitory protein CD59 in human seminal plasma: CD59 is present on extra cellular organelles (prostasomes), binds cell membranes, and inhibits complement-mediated lysis. J Exp Med 1993; 177: 1409–20
   PubMed Web of Science ®Google Scholar
• Kitamura M, Namiki M, Matsumiya K, Tanaka K, Matsumoto M, Hara T, et al. Membrane cofactor protein (CD46) in seminal plasma is a prostasome-bound form with complement regulatory activity and measles virus neutralising activity. Immunology 1995; 84: 626–32
   PubMed Web of Science ®Google Scholar
• Babiker AA, Nilsson B, Ronquist G, Carlsson L, Ekdahl KN. Transfer of functional prostasomal CD59 of metastatic prostatic cancer cell origin protects cells against complement attack. Prostate 2005; 62: 105–14
   PubMed Web of Science ®Google Scholar
• Jiang H, Pillai S. Complement regulatory proteins on the sperm surface. Relevance to sperm motility. Am J Reprod Immunol 1998; 39: 243–8
   PubMed Web of Science ®Google Scholar
• Fernandez JA, Heeb MJ, Radtke KP, Griffin JH. Potent blood coagulant activity of human semen due to prostasome-bound tissue factor. Biol Reprod 1997; 56: 757–63
   PubMed Web of Science ®Google Scholar
• Ronquist G, Nilsson BO. The Janus-faced nature of prostasomes: their pluripotency favours the normal reproductive process and malignant prostate growth. Prostate Cancer Prostatic Dis 2004; 7: 21–31
   PubMed Web of Science ®Google Scholar
• Stewart AB, Anderson W, Delves G, Lwaleed BA, Birch B, Cooper A. Prostasomes: a role in prostatic disease?. BJU Int 2004; 94: 985–9
   PubMed Web of Science ®Google Scholar
• Carlsson L, Nilsson O, Larsson A, Stridsberg M, Sahlen G, Ronquist G. Characteristics of human prostasomes isolated from three different sources. Prostate 2003; 54: 322–30
   PubMed Web of Science ®Google Scholar
• Sahlen G, Ahlander A, Frost A, Ronquist G, Norlen BJ, Nilsson BO. Prostasomes are secreted from poorly differentiated cells of prostate cancer metastases. Prostate 2004; 61: 291–7
   PubMed Web of Science ®Google Scholar
• Delves GH, Stewart AB, Lwaleed BA, Cooper AJ. In vitro inhibition of angiogenesis by prostasomes. Prostate Cancer Prostatic Dis 2005; 8: 174–8
   PubMed Web of Science ®Google Scholar
• Nilsson BO, Carlsson L, Larsson A, Ronquist G. Auto antibodies to prostasomes as new markers for prostate cancer. Ups J Med Sci 2001; 106: 43–9
   PubMed Web of Science ®Google Scholar
• Carlsson L, Nilsson BO, Ronquist G, Lundqvist M, Larsson A. A new test for immunological infertility: an ELISA based on prostasomes. Int J Androl 2004; 27: 130–3
   PubMedGoogle Scholar
• Allegrucci C, Ronquist G, Ove Nilsson B, Carlsson L, Lundqvist M, Minelli A, et al. Circulating human antisperm antibodies recognize prostasomes. Am J Reprod Immunol 2001; 46: 211–9
   PubMed Web of Science ®Google Scholar
• Minelli A, Ronquist G, Carlsson L, Mearini E, Nilsson O, Larsson A. Antiprostasome antibody titres in benign and malignant prostate disease. Anticancer Res 2005; 25: 4399–402
   PubMed Web of Science ®Google Scholar
• Larsson A, Ronquist G, Wülfing C, Eltze E, Bettendorf O, Carlsson L, et al. Antiprostasome antibodies: possible serum markers for prostate cancer metastasizing liability. Urol Oncol 2006; 24: 195–200
   PubMed Web of Science ®Google Scholar
• Carlsson L, Larsson A, Ronquist G, Nilsson BO. Prostasome antigens as targets for sperm agglutinating antibodies demonstrated by 1-D gel electrophoresis and immunoblottings. Int J Androl 2004; 27: 360–7
   PubMedGoogle Scholar
• Carlsson L, Lennartsson L, Nilsson BO, Nilsson S, Ronquist G. Growth Inhibitory effect of prostasomes on prostatic cancer cell lines in culture. Eur Urol 2000; 38: 468–74
   PubMed Web of Science ®Google Scholar
• Stegmayr B, Gottfries G, Ronquist A, Brody I. Reduced activity of Mg2 + and Ca2 + dependent adenosine triphosphatase in seminal fluid of patients with oligozoospermia. Scand J Urol Nephrol 1980; 14: 129–34
   PubMed Web of Science ®Google Scholar
• Nilsson BO, Lennartsson L, Carlsson L, Nilsson S, Ronquist G. Expression of prostasome-like granules by the prostate cancer cell lines PC3, Du145 and LnCaP grown in monolayer. Ups J Med Sci 1999; 104: 199–206
   PubMed Web of Science ®Google Scholar
• Morris MJ, Scher HI. Novel strategies and therapeutics for the treatment of prostate carcinoma. Cancer 2000; 89: 1329–48
   PubMed Web of Science ®Google Scholar
• Catalona WJ. Immunobiology of carcinoma of the prostate. Invest Urol 1980; 17: 373–7
   PubMedGoogle Scholar